Zacks Research Has Bearish Forecast for A Q1 Earnings

Agilent Technologies, Inc. (NYSE:A) – Equities research analysts at Zacks Research reduced their Q1 2026 earnings per share (EPS) estimates for Agilent Technologies in a report issued on Monday, December 15th. Zacks Research analyst Team now forecasts that the medical research company will earn $1.36 per share for the quarter, down from their previous forecast of $1.38. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.58 per share. Zacks Research also issued estimates for Agilent Technologies’ Q2 2026 earnings at $1.40 EPS, Q3 2026 earnings at $1.46 EPS, Q4 2026 earnings at $1.68 EPS, FY2026 earnings at $5.90 EPS, Q1 2027 earnings at $1.52 EPS, Q4 2027 earnings at $1.77 EPS, FY2027 earnings at $6.48 EPS and FY2028 earnings at $7.30 EPS.

A number of other brokerages also recently commented on A. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. UBS Group raised their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Rothschild & Co Redburn began coverage on Agilent Technologies in a research note on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. Bank of America increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. Finally, Evercore ISI raised their target price on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.77.

Agilent Technologies Trading Down 1.1%

Shares of A stock opened at $139.08 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The firm’s 50 day moving average price is $145.58 and its two-hundred day moving average price is $129.66. The stock has a market cap of $39.43 billion, a price-to-earnings ratio of 30.43, a price-to-earnings-growth ratio of 4.08 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS.

Institutional Trading of Agilent Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank bought a new position in shares of Agilent Technologies during the second quarter worth about $395,088,000. AQR Capital Management LLC increased its holdings in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after buying an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after buying an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after buying an additional 1,273,994 shares during the last quarter. Finally, Troy Asset Management Ltd grew its position in shares of Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after acquiring an additional 1,021,865 shares in the last quarter.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. The trade was a 27.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 16,401 shares of company stock worth $2,468,962.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 21.66%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.